Innventure Earnings Calls
| Release date | May 14, 2026 |
| EPS estimate | -$0.360 |
| EPS actual | -$0.260 |
| EPS Surprise | 27.78% |
| Revenue estimate | 1.645M |
| Revenue actual | 1.443M |
| Revenue Surprise | -12.26% |
| Release date | Mar 30, 2026 |
| EPS estimate | -$0.320 |
| EPS actual | -$0.690 |
| EPS Surprise | -115.63% |
| Revenue estimate | 2.012M |
| Revenue actual | 826K |
| Revenue Surprise | -58.95% |
| Release date | Nov 13, 2025 |
| EPS estimate | -$0.240 |
| EPS actual | -$0.510 |
| EPS Surprise | -112.50% |
| Revenue estimate | 2.012M |
| Revenue actual | 534K |
| Revenue Surprise | -73.46% |
| Release date | Aug 14, 2025 |
| EPS estimate | -$0.170 |
| EPS actual | -$1.60 |
| EPS Surprise | -841.18% |
| Revenue estimate | 3.852M |
| Revenue actual | 476K |
| Revenue Surprise | -87.64% |
Last 4 Quarters for Innventure
Below you can see how INV performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $4.70 |
| EPS estimate | -$0.170 |
| EPS actual | -$1.60 |
| EPS surprise | -841.18% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $4.80 |
| Aug 11, 2025 | $4.72 |
| Aug 12, 2025 | $4.74 |
| Aug 13, 2025 | $4.67 |
| Aug 14, 2025 | $4.70 |
| Aug 15, 2025 | $4.39 |
| Aug 18, 2025 | $4.16 |
| Aug 19, 2025 | $4.14 |
| Aug 20, 2025 | $4.11 |
| 4 days before | -2.08% |
| 4 days after | -12.55% |
| On release day | -6.60% |
| Change in period | -14.38% |
| Release date | Nov 13, 2025 |
| Price on release | $3.69 |
| EPS estimate | -$0.240 |
| EPS actual | -$0.510 |
| EPS surprise | -112.50% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $4.09 |
| Nov 10, 2025 | $4.27 |
| Nov 11, 2025 | $4.08 |
| Nov 12, 2025 | $3.71 |
| Nov 13, 2025 | $3.69 |
| Nov 14, 2025 | $3.24 |
| Nov 17, 2025 | $4.03 |
| Nov 18, 2025 | $3.59 |
| Nov 19, 2025 | $3.35 |
| 4 days before | -9.78% |
| 4 days after | -9.21% |
| On release day | -12.20% |
| Change in period | -18.09% |
| Release date | Mar 30, 2026 |
| Price on release | $3.61 |
| EPS estimate | -$0.320 |
| EPS actual | -$0.690 |
| EPS surprise | -115.63% |
| Date | Price |
|---|---|
| Mar 24, 2026 | $4.19 |
| Mar 25, 2026 | $4.38 |
| Mar 26, 2026 | $4.01 |
| Mar 27, 2026 | $3.80 |
| Mar 30, 2026 | $3.61 |
| Mar 31, 2026 | $3.91 |
| Apr 01, 2026 | $4.28 |
| Apr 02, 2026 | $4.64 |
| Apr 06, 2026 | $4.68 |
| 4 days before | -13.84% |
| 4 days after | 29.64% |
| On release day | 8.31% |
| Change in period | 11.69% |
| Release date | May 14, 2026 |
| Price on release | $7.32 |
| EPS estimate | -$0.360 |
| EPS actual | -$0.260 |
| EPS surprise | 27.78% |
| Date | Price |
|---|---|
| May 08, 2026 | $7.00 |
| May 11, 2026 | $6.99 |
| May 12, 2026 | $6.81 |
| May 13, 2026 | $7.15 |
| May 14, 2026 | $7.32 |
| May 15, 2026 | $6.72 |
| May 18, 2026 | $6.28 |
| May 19, 2026 | $5.98 |
| May 20, 2026 | $6.20 |
| 4 days before | 4.57% |
| 4 days after | -15.30% |
| On release day | -8.20% |
| Change in period | -11.43% |
Innventure Earnings Call Transcript Summary of Q1 2026
Key points for investors: Innventure reported Q1 2026 consolidated revenue of $1.4M (Accelsius $1.3M), continuing sequential growth. Management highlights governance improvements (two board candidates added) and active shareholder engagement. Commercial momentum: $50M of bookings in Q1, with continued pipeline progression across operating companies. Accelsius: strategic partnership with Legrand, GTC debut of the NeuCool IR150 (rack-level 2-phase solution), a large pipeline, and management expectation that Accelsius will exit Dec 2026 at positive operating cash flow, implying an approximate $100M annualized revenue run rate. AeroFlexx: pipeline expanded to $32M, $13.2M in late-stage negotiations, Aveda anchor program driving credibility and expected launches beginning 2027; manufacturing capacity expanded via Packaging Imolese (Italy) and several compliance certifications obtained. Refinity: detailed design of a 10-kiloton demonstration plant underway, pilot trials producing target olefin yields, ongoing integration work with Dow, seeking offtake partners and nondilutive funding to support CapEx. Financials & liquidity: Q1 net loss attributable to Innventure stockholders was $20.8M and adjusted EBITDA was -$18.4M. G&A fell Y/Y to $12.7M; cash and restricted cash ended at $60.4M (down $5.1M YTD). Post-quarter, the company accessed equity facility raising about $11.9M. Management emphasizes disciplined capital strategy to minimize dilution and believes current liquidity plus opportunistic raises extend runway, with no anticipated need for significant near-term capital raises. Key risks remain execution timing, customer procurement/permitting delays, and early-stage lumpiness of bookings.
Sign In
Buy INV